Current Studies

Publications

Abstracts

Works In Progress

Prostate Cancer

Current Studies

Upcoming Events

- Anesthesia Protocol for Brachytherapy - June 2000

- Urinary Morbidity After Brachytherapy Using Cs-131 - October 2007

- Erectile Function and Potency Following Brachytherapy - October 2003

- Fusion Technique for Post-Implant CT-Scans - October 2001

- Efficacy of Treating Gleason 7 Patients with Brachytherapy - May 2006

- Iodine Allergy in I-125 Brachytherapy Patients - November 2005

- Effectiveness of Brachytherapy in Morbidly Obese Patients - Nov 2005

- Incidence of Pain After Brachytherapy - October 2003

- Prevention of Perineal Hematoma After Brachytherapy - December 2000

- Stainless Steel Needle in I-125/Pd-103 Implants - December 2000

- Salvage Brachytherapy After Failed EBRT - December 2000

- Seed Loss Through Urinary Tract After Brachytherapy - December 2002

- Detection Rate and Morbidity of STP Re-Biopsy - February 2005

- Patient Treatment Decisions Following STPB - February 2007

- Urinary Symptoms Post-Brachytherapy With Previous TURP - April 2002

- CUO In Brachytherapy Patients With Previous TURP/TUIP - May 2001

- Risk Factors for Urinary Retention Following Brachytherapy - May 2005

- Effect of Hormonal Manipulation on Prostate Volume - November 2005

- Brachytherapy's Effect on Patient's Spouse or Partner - October 2004

- Detection and Morbidity of Stereotactic Transperineal Re-Biopsy - 2006

- Urinary Morbidity Post-Brachy in Patients With Previous TURP - 2004

- Seed Loss Through Urinary Tract Following Brachytherapy - 2003

- Update on Cs-131 vs. I-125 Prospective Randomized Trial

- Stereotactic Transperineal Prostate Biopsy

- Review of Complications in Brachytherapy

- Androgen Deprivation and Cardiac Death in Brachytherapy Patients

- Radiation Exposure with Cesium-131

- 10 Years of Brachytherapy

Prostate Cancer Foundation of Chicago

- Advanced Biopsy Technique Detects 40% More Cancers

- Prostate cancer cure rates-the Chicago Experience

- Cause-specific mortality in prostate cancer patients

- Urinary morbidity similar in Cesium-131 vs. Iodine-125